Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

2.81
Delayed Data
As of Apr 25
 +0.04 / +1.44%
Today’s Change
1.82
Today|||52-Week Range
7.69
-23.85%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues5.7M3.1M2.5M669.0K
 
 
 
 
 
Depreciation And Amortization29.0K27.0K11.0K9.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses50.7M42.3M39.0M35.1M
 
 
 
 
 
Research And Development27.7M23.7M22.9M21.5M
 
 
 
 
 
Total Operating Expenses50.8M42.4M39.0M35.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-45.0M-39.3M-36.5M-34.4M
 
 
 
 
 
Extraordinary Credit3.9M3.5M0.000.00
 
 
 
Interest Expense On Debt1.7M939.0K1.7M1.4M
 
 
 
 
 
Other Expenses-132.0K22.0K158.0K357.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-43.0M-36.7M-38.0M-35.5M
 
 
 
 
 
Net Income-43.0M-36.7M-38.0M-35.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.0M12.2M15.7M24.5M
 
 
 
 
 
Shares To Calculate EPS Diluted10.3M12.2M15.7M24.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.56-$3.00-$2.42-$1.45
 
 
 
 
 
EPS Diluted-$4.56-$3.00-$2.42-$1.45